Chlamydial Infection: A Clinical and Public Health Perspective
Chlamydiae are obligate intracellular bacteria that cause one of the most common sexually transmitted infectious diseases in the world. The infection disproportionately impacts women and the highest prevalence of infection is found in adolescents. Most chlamydial infections are asymptomatic. Untreated infections are sources of further spread of infection and can lead to serious consequences including pelvic inflammatory disease, infertility and chronic pelvic pain. Chlamydial infections also increase a person’s susceptibility to HIV and other STDs. Featuring contributions by internationally recognized experts in epidemiology, infectious disease research and chlamydial biology, this book provides up-to-date reviews from a clinical and public health perspective on chlamydia epidemiology and control programs, genomics and pathogenicity, diagnosis, treatment, host immune responses, and the latest on the search for an effective vaccine. Also included are chapters on the impact of chlamydial infection on specific populations such as the lesbian, gay, bisexual and transgender community, and an update on the outbreak in Europe of the invasive chlamydial infection, lymphogranuloma venereum or LGV. This comprehensive publication is intended for clinicians, public health workers and scientists with interest in sexually transmitted diseases, medical microbiology, infectious diseases and clinical research.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 8: IntroductionByCarolyn M. BlackCarolyn M. BlackDivision of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga., USASearch for other works by this author on:
-
9 - 24: Epidemiology and Prevention and Control Programs for ChlamydiaByCatherine L. Satterwhite;Catherine L. SatterwhiteDivision of STD Prevention and National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga., USASearch for other works by this author on:John M. Douglas, Jr.John M. Douglas, Jr.Division of STD Prevention and National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga., USASearch for other works by this author on:
-
25 - 60: Chlamydia trachomatis Pathogenicity and DiseaseByDeborah DeanDeborah DeanCenter for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, Calif., and Department of Bioengineering, University of California at Berkley and San Francisco, Calif., USASearch for other works by this author on:
-
61 - 77: Chlamydia trachomatis Genome StructureByTimothy E. Putman;Timothy E. PutmanDepartment of Biomedical Sciences and the Molecular and Cellular Biology Program, College of Veterinary Medicine, Oregon State University, Corvallis, Oreg., USASearch for other works by this author on:Daniel D. RockeyDaniel D. RockeyDepartment of Biomedical Sciences and the Molecular and Cellular Biology Program, College of Veterinary Medicine, Oregon State University, Corvallis, Oreg., USASearch for other works by this author on:
-
78 - 88: Chlamydia trachomatis: Molecular Testing MethodsByCharlotte A. GaydosCharlotte A. GaydosDivision of Infectious Diseases, Johns Hopkins University, Baltimore, Md., USASearch for other works by this author on:
-
89 - 96: Treatment of Chlamydia trachomatis InfectionsByMargaret R. HammerschlagMargaret R. HammerschlagDivision of Pediatric Infectious Diseases, Departments of Pediatrics and Medicine, SUNY Downstate Medical Center, Brooklyn, N.Y., USASearch for other works by this author on:
-
97 - 114: The Immunologic Response to Urogenital InfectionByRaymond M. Johnson;Raymond M. JohnsonaMicrobiology and Immunology, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Ind., andSearch for other works by this author on:William GeislerWilliam GeislerbDepartment of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, Birmingham, Ala., USASearch for other works by this author on:
-
115 - 130: Chlamydia Vaccine DevelopmentByJoseph U. Igietseme;Joseph U. IgietsemeNational Center for Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga., USASearch for other works by this author on:Carolyn M. BlackCarolyn M. BlackNational Center for Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga., USASearch for other works by this author on:
-
131 - 141: Maternal and Infant Chlamydia trachomatis InfectionsByIngrid G.I.J.G. Rours;Ingrid G.I.J.G. RoursaDepartment of Pediatrics, Sophia Children's Hospital, Erasmus MC University Medical Center, Rotterdam, The Netherlands;Search for other works by this author on:Margaret R. HammerschlagMargaret R. HammerschlagbDivision of Pediatric Infectious Diseases, Departments of Pediatrics and Medicine, SUNY Downstate Medical Center, Brooklyn, N.Y., USASearch for other works by this author on:
-
142 - 150: Chlamydia trachomatis Infection among Sexual MinoritiesByDevika Singh;Devika SinghHarborview Medical Center, Seattle, Wash., USASearch for other works by this author on:Jeanne M. MarrazzoJeanne M. MarrazzoHarborview Medical Center, Seattle, Wash., USASearch for other works by this author on:
-
151 - 157: Lymphogranuloma Venereum: A Concise Outline of an Emerging Infection among Men Who Have Sex with MenByHenry J.C. de Vries;Henry J.C. de VriesaDepartment of Dermatology, Academic Medical Centre, University of Amsterdam,bSTI Outpatient Clinic, Infectious Disease Cluster, Public Health Service Amsterdam, anddCentre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The NetherlandsSearch for other works by this author on:Servaas MorréServaas MorrécDepartment of Pathology, Laboratory of Immunogenetics, VU University Medical Centre, Amsterdam, andSearch for other works by this author on:
